UCB BIOPHARMA SRL - BE 

Ranking results:

Past rankings:

2020
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
2019
Criterium:Position:
Overall Score:600-700
Total Project Funding per Partner:> 1000
Total Number of Projects:400-500

Ranking timeline:

Project Participation Performance(2019-01-01 - 2024-12-31 ):

Total Project Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:

Leadership:

Total number of projects: 14
As coordinator: 0
As participant: 14
Sole participant: 0
Coordinator / Participant Ratio: 0*

*Ratio includes only projects with > 2 partners

Summary:

Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2021 0 52.210.818 0 3
2020 0 21.592.662 256.320 3
2019 0 84.254.102 0 8
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:

Institution:Projects [No]:
PFIZER LIMITED10
NOVARTIS PHARMA9
JANSSEN PHARMACEUTICA NV7
SANOFIAVENTIS7
ASTRAZENECA5
BAYER5
BOEHRINGER INGELHEIM PHARMA GMBH &CO KG5
F HOFFMANNLA ROCHE5
KATHOLIEKE UNIVERSITEIT LEUVEN5
TAKEDA PHARMACEUTICALS INTERNATIONAL5
NOVO NORDISK4
TAKEDA DEVELOPMENT CENTRE EUROPE4
TEVA PHARMACEUTICAL INDUSTRIES LIMITED4
THE EUROPEAN INSTITUTE FOR INNOVATION THROUGH HEALTH DATA4
ABBVIE INC3
BIOBANKS AND BIOMOLECULAR RESOURCES RESEARCH INFRASTRUCTURE CONSORTIUM3
CENTRE HOSPITALIER UNIVERSITAIRE VAUDOIS3
ELI LILLY AND COMPANY LIMITED3
FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E V3
KAROLINSKA INSTITUTE3
KING'S COLLEGE LONDON3
STICHTING LYGATURE3
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD3
THE UNIVERSITY OF MANCHESTER3
UNIVERSITAIR MEDISCH CENTRUM UTRECHT3
UPPSALA UNIVERSITET3
ACADEMIC MEDICAL CENTRE AMSTERDAM2
ACADEMISCH ZIEKENHUIS GRONINGEN2
AGENTSCHAP COLLEGE TER BEOORDELING VAN GENEESMIDDELEN2
BRISTOLMYERS SQUIBB COMPANY CORP2
CONSIGLIO NAZIONALE DELLE RICERCHE2
DEUTSCHES ZENTRUM FUR NEURODEGENERATIVE ERKRANKUNGEN EV2
DREEM2
EMPIRICA GESELLSCHAFT FUR KOMMUNIKATIONS UND TECHNOLOGIEFORSCHUNG MBH2
ETHNIKO KENTRO EREVNAS KAI TECHNOLOGIKIS ANAPTYXIS2
EURICE EUROPEAN RESEARCH AND PROJECT OFFICE2
EUROPEAN FORUM FOR GOOD CLINICAL PRACTICE2
FORUM DES PATIENTS EUROPEENS2
FUJIFILM CELLULAR DYNAMICS INC2
FUNDACION PARA EL FOMENTO DE LA INVESTIGACION SANITARIA Y BIOMEDICA DE LA COMUNITAT VALENCIANA2
GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT2
H LUNDBECK AS2
LEIDS UNIVERSITAIR MEDISCH CENTRUM2
MEDIZINISCHE UNIVERSITAET WIEN2
MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN2
MERCK SHARP & DOHME CORP2
PARKINSON'S DISEASE SOCIETY OF THEUNITED KINGDOM LBG2
STICHTING KATHOLIEKE UNIVERSITEIT2
STICHTING MLC FOUNDATION2
TECHNISCHE UNIVERSITAET MUENCHEN2
THE PROVOST FELLOWS AND SCHOLARS OF THE COLLEGE OF THE HOLY AND UNDIVIDED TRINITY OF QUEEN ELIZABETH NEAR DUBLIN HEREINAFTER TRINITY COLLEGE DUBLIN2
THE SYNERGIST2
TTOPSTART BV2
UNIVERSIDAD POLITECNICA DE MADRID2
UNIVERSITA CATTOLICA DEL SACRO CUORE2
UNIVERSITAT WIEN2
UNIVERSITE DE GENEVE2
UNIVERSITE DU LUXEMBOURG2
UNIVERSITEIT MAASTRICHT2
UNIVERSITY COLLEGE DUBLIN2
UNIVERSITY COLLEGE LONDON2
UNIVERSITY OF COPENHAGEN2
UNIVERSITY OF DUNDEE2
UNIVERSITY OF EASTERN FINLAND2
UNIVERSITY OF GLASGOW2
UNIVERSITY OF OSLO2
A PERSIDIS & SIA OE1
AC IMMUNE1
ACIB1
AGENCIA ESPANOLA DE MEDICAMENTOS Y PRODUCTOS SANITARIOS1
AGENZIA REGIONALE DI SANITA1
AGES OSTERREICHISCHE AGENTUR FUR GESUNDHEIT UND ERNAHRUNGSSICHERHEIT1
AKERSHUS UNIVERSITETSSYKEHUS HF1
ALCEDIAG1
ALLERGAN LIMITED1
ALZHEIMER EUROPE1
ARIDHIA INFORMATICS LIMITED1
ARTEEVO TECHNOLOGIES1
ARTTIC1
ARTTIC INNOVATION1
ASOCIACION PARKINSON MADRID1
ATTUROS LIMITED1
AUSTRIAN RESEARCH CENTERS SIEBERDORF1
AZIENDA OSPEDALIERA PER L EMERGENZA CANNIZZARO1
BAXALTA INNOVATIONS1
BETH ISRAEL DEACONESS MEDICAL CENTER INC NON PROFIT CORPORATION1
BIOGEN IDEC LIMITED1
BIONEER1
BIONOTUS1
BMD SOFTWARE LDA1
BYONDIS BV1
BYTEFLIES1
CAMBRIDGE COGNITION LIMITED1
CENTRE DE RECHERCHE PUBLIC DE LA SANTE1
CENTRE HOSPITALIER UNIVERSITAIRE DE TOULOUSE1
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE1
CHARITE UNIVERSITAETSMEDIZIN BERLIN1
CHRISTIAN ALBRECHTS UNIVERSITAET ZU KIEL1
COVANCE CLINICAL AND PERIAPPROVAL SERVICES1
COVANCE LABORATORIES1

Constancy:

Total number of partners: 411
Partner loyalty:
Frequent Partner: (> 2 projects): 115
Rare Partner: 296
Frequent / Rare Partner Ratio: 0.39

Project overview:

Start dateProjectacronymrolefundingpartners
2021-11-01European platform for neurodegenerative disorders EPNDparticipant9.680.00029
2021-07-01Health Initiatives in Psoriasis and PsOriatic arthritis ConsoRTium European States HIPPOCRATESparticipant10.210.99327
2021-02-01Central Repository for Digital Pathology BIGPICTUREparticipant32.319.82551
2020-11-01Gravitate–Health: Empowering and Equipping Europeans with health information for Active Personal Health Management and Adherence to Treatment Gravitate-Healthparticipant9.280.00042
2020-01-01PharmaLedger PharmaLedgerparticipant8.290.69430
2020-01-01INnovation in Safety Pharmacology for Integrated cardiovascular safety assessment to REduce adverse events and late stage drug attrition. INSPIREparticipant4.021.96911
2019-11-01Identifying Digital Endpoints to Assess FAtigue, Sleep and acTivities in daily living in Neurodegenerative disorders and Immune-mediated inflammatory diseases IDEA-FASTparticipant20.997.52347
2019-09-01Trials@Home: Center of Excellence – Remote Decentralised Clinical Trials Trials@Homeparticipant19.036.99833
2019-04-01Building an ecosystem for better monitoring and communicating of medication safety in pregnancy and breastfeeding: validated and regulatory endorsed workflows for fast, optimised evidence generation ConcePTIONparticipant15.299.99153
2019-04-01Biomarkers in Atopic Dermatitis and Psoriasis BIOMAPparticipant10.500.00032
2019-03-01EBiSC2 – A sustainable European Bank for induced pluripotent Stem Cells EBiSC2participant4.599.64818
2019-03-01Neurotoxicity De-Risking in Preclinical Drug Discovery NeuroDeRiskparticipant5.331.00018
2019-02-01PD-MitoQUANT – A quantitative approach towards the characterisation of mitochondrial dysfunction in Parkinson's disease PD-MitoQUANTparticipant4.497.93514
2019-02-01Continuous Downstream Processing of Bioproducts CODOBIOparticipant3.991.00820